Bruce B, Fries JF, Murtagh KN Health status disparities in ethnic minority patients with rheumatoid arthritis: a cross-sectional study. J Rheumatol. 2007 Jul;34(7):1475-9. Epub 2007 Jun 1.
Cano A, Mayo A, Ventimiglia M Coping, pain severity, interference, and disability: the potential mediating and moderating roles of race and education. J Pain. 2006 Jul;7(7):459-68. Erratum in: J Pain. 2006 Nov;7(11):869-70.
Chapman WP, Jones CM VARIATIONS IN CUTANEOUS AND VISCERAL PAIN SENSITIVITY IN NORMAL SUBJECTS. J Clin Invest. 1944 Jan;23(1):81-91.
France CR Decreased pain perception and risk for hypertension: considering a common physiological mechanism. Psychophysiology. 1999 Nov;36(6):683-92. Review.
Ghione S Hypertension-associated hypalgesia. Evidence in experimental animals and humans, pathophysiological mechanisms, and potential clinical consequences. Hypertension. 1996 Sep;28(3):494-504. Review.
Golightly YM, Dominick KL Racial variations in self-reported osteoarthritis symptom severity among veterans. Aging Clin Exp Res. 2005 Aug;17(4):264-9.
Gurevich M, Kohn PM, Davis C Exercise-induced analgesia and the role of reactivity in pain sensitivity. J Sports Sci. 1994 Dec;12(6):549-59.
Janal MN, Colt EW, Clark WC, Glusman M Pain sensitivity, mood and plasma endocrine levels in man following long-distance running: effects of naloxone. Pain. 1984 May;19(1):13-25.
Kellogg DL Jr, Liu Y, Kosiba IF, O'Donnell D Role of nitric oxide in the vascular effects of local warming of the skin in humans. J Appl Physiol (1985). 1999 Apr;86(4):1185-90.
Kemppainen P, Hämäläinen O, Könönen M Different effects of physical exercise on cold pain sensitivity in fighter pilots with and without the history of acute in-flight neck pain attacks. Med Sci Sports Exerc. 1998 Apr;30(4):577-82.
Kemppainen P Modification of human dental pain thresholds by conditioning stimulation. Proc Finn Dent Soc. 1985;81 3-4:1-67.
Klonoff EA Disparities in the provision of medical care: an outcome in search of an explanation. J Behav Med. 2009 Feb;32(1):48-63. doi: 10.1007/s10865-008-9192-1. Epub 2009 Jan 6. Review.
Kodesh E, Weissman-Fogel I Exercise-induced hypoalgesia - interval versus continuous mode. Appl Physiol Nutr Metab. 2014 Jul;39(7):829-34. doi: 10.1139/apnm-2013-0481. Epub 2014 Feb 12.
Lovick TA Integrated activity of cardiovascular and pain regulatory systems: role in adaptive behavioural responses. Prog Neurobiol. 1993 May;40(5):631-44. Review.
Mechlin B, Heymen S, Edwards CL, Girdler SS Ethnic differences in cardiovascular-somatosensory interactions and in the central processing of noxious stimuli. Psychophysiology. 2011 Jun;48(6):762-73. doi: 10.1111/j.1469-8986.2010.01140.x. Epub 2010 Oct 29.
Siedlecki SL Racial variation in response to music in a sample of African-American and Caucasian chronic pain patients. Pain Manag Nurs. 2009 Mar;10(1):14-21. doi: 10.1016/j.pmn.2008.08.003.
Umeda M, Kempka LE, Greenlee BT, Weatherby AC A smaller magnitude of exercise-induced hypoalgesia in African Americans compared to non-Hispanic Whites: A potential influence of physical activity. Biol Psychol. 2016 Jan;113:46-51. doi: 10.1016/j.biopsycho.2015.11.006. Epub 2015 Nov 28.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.